Thermoplastics supplier expands healthcare focus

Solvay Specialty Polymers is making changes to expand its focus on the healthcare industry and meet the growing needs of its global customers.

The global supplier of high-performance thermoplastics for use in a range of markets including implantable and non-implantable medical devices has named Maria Gallahue-Worl (pictured) as business manager-healthcare. Gallahue-Worl to oversee Solvay’s global healthcare business team, which will now focus on the medical implant market, the hemodialysis market, and new future growth segments within the global healthcare industry. Solvay’s non-implant business includes medical grade plastics for instrumentation, reusable and single-use devices, medical equipment, and sterilization cases and trays. Over the last two years, Gallahue-Worl has been responsible for Solvay’s non-implant healthcare business which has seen significant sales growth.

“With our broad product portfolio, we are firmly positioned as a strategic supplier to the healthcare industry and the organizational changes signal our further commitment to our customers,” said Gallahue-Worl. “We are leveraging our extensive expertise in polymer manufacturing and adding substantial new resources to give our customers a competitive edge in meeting their end-use requirements.”

Other key appointments include Dane Waund as global market manager-healthcare, focusing on the hemodialysis market and non-implant healthcare marketing activities. Shawn Shorrock has also been named director of global regulatory affairs for the healthcare business.